risk, we strongly recommend continuing OP therapy (PICO 12.1-12.6).  Recommendations for initial treatment (Table 2 3 For adults ≥40 years with very high fracture risk, we conditionally recommend PTH/PTHrP over anti-resorptives (BP or DEN) (PICO 1.13c, 1.14c, 1.15c, 1.18c, 1.19c, 1.20c). Compared to alendronate, teriparatide increased lumbar and hip BMD and decreased vertebral but not nonvertebral fractures at 36 months in GIOP For adults ≥40 years with high or very high fracture risk, we